Results

Frequency Therapeutics Inc.

02/22/2021 | Press release | Distributed by Public on 02/23/2021 03:39

Frequency Therapeutics Announces Publication of Phase 1/2 Data Showing Hearing Improvements in Acquired Sensorineural Hearing Loss Patients Receiving FX-322